FDA RETALIATION ALLEGATIONS SHOULD BE INVESTIGATED THROUGH "INDEPENDENT" OUTSIDE PROCESS, BARTON TELLS KESSLER AT OVERSIGHT SUBCOMMITTEE HEARING
This article was originally published in The Gray Sheet
Executive Summary
House Commerce/Oversight Subcommittee Chairman Joe Barton (R-Tex.) will push to require that an outside investigative body handle allegations of retaliation under any FDA reform package released by the committee.